Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Proinflammatory stimuli, after amyloid β (Aβ) deposition, have been hypothesized to create a self‐reinforcing positive feedback loop that increases amyloidogenic processing of the Aβ precursor protein (APP), promoting further Aβ accumulation and neuroinflammation in Alzheimer's disease (AD). Interleukin‐6 (IL‐6), a proinflammatory cytokine, has been shown to be increased in AD patients implying a pathological interaction. To assess the effects of IL‐6 on Aβ deposition and APP processing in vivo ,we overexpressed murine IL‐6 (mIL‐6) in the brains of APP transgenic TgCRND8 and TG2576 mice. mIL‐6 expression resulted in extensive gliosis and concurrently attenuated Aβ deposition in TgCRND8 mouse brains. This was accompanied by up‐regulation of glial phagocytic markers in vivo and resulted in enhanced microglia‐mediated phagocytosis of Aβ aggregates in vitro . Further, mIL‐6‐induced neuroinflammation had no effect on APP processing in TgCRND8 and had no effect on APP processing or steady‐state levels of Aβ in young Tg2576 mice. These results indicate that mIL‐6‐mediated reactive gliosis may be beneficial early in the disease process by potentially enhancing Aβ plaque clearance rather than mediating a neurotoxic feedback loop that exacerbates amyloid pathology. This is the first study that methodically dissects the contribution of mIL‐6 with regard to its potential role in modulating Aβ deposition in vivo .—Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., Das, P. Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J . 24, 548–559 (2010). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“administration or expression of IFN-γ, TNF or IL-6 in the mouse CNS reduced Aβ deposition [48–50]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [50]
In the citing paper
“For example, increased gliosis induced by brain infusion of lipopolysaccharide (4) or overexpression of the inflammatory cytokine interleukin-6 (5) or interferon-γ (6) markedly reduces amyloid plaque burden.”
From Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice (2013) · cites this paper as [5]
In the citing paper
“Strikingly, activation of microglial cells by inflammatory molecules has been shown to enhance Aβ clearance by microglia [3, 26, 27].”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [3]
In the citing paper
“For amyloid pathology, there is data that activated micro/astroglia enhances Aβ phagocytosis [60, 62, 71]”
From Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways (2022) · cites this paper as [71]
In the citing paper
“mice overexpressing IL-6 (127) or IFN-γ (128) had enhanced microglial phagocytosis of Aβ accompanied by an increase in complement component mRNA levels, TNF-α, and other inflammatory mediators.”
From Microglia in Alzheimer's disease (2017) · cites this paper as [127]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 1×
“Since microglia in close apposition to the plaques could display different phenotypes, we decided to further investigate whether mIL-6 overexpression led to the establishment of a neuroprotective alternative M2 glial phenotype, marked by expression of Ym-1 and arginase or whether there was a prevalence of the classica…”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
Cited by
Items 201–300 of 339
Guha, S., Paidi, R. K., Goswami, S., Saha, P., & Biswas, S. C. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.021 · Cited by 26
Li, H., Sun, J., Miao, Z., Chen, S., & Yang, G. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13411 · Cited by 31
Prat, A., Behrendt, M., Marcinkiewicz, E., Boridy, S., Sairam, R. M., Seidah, N. G., & Maysinger, D. (2011) · Journal of Aging Research · doi:10.4061/2011/251517 · Cited by 27
Wtpsk, S., Oikari, L. E., Bharadwaj, P., Jayasena, V., Martins, R. N., & Fernando, W. M. A. D. B. (2025) · Nutrients · doi:10.3390/nu17142286 · Cited by 27
Koller, E. J., Ibanez, K. R., Vo, Q., McFarland, K. N., Gonzalez De La Cruz, E., Zobel, L., Williams, T., Xu, G., Ryu, D., Patel, P., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12779 · Cited by 23
Self-citationZhang, Y., Wang, Y., Zhou, Z., Yang, Y., Zhao, J., Kang, X., Li, Z., Shen, X. P., He, F., & Cheng, R. (2024) · Nutrients · doi:10.3390/nu16060844 · Cited by 25
The role of Alu-derived RNAs in Alzheimer’s and other neurodegenerative conditions
Polesskaya, O., Kananykhina, E. Y., Roy‐Engel, A. M., Nazarenko, O., Kulemzina, I. A., Baranova, A. V., Vassetzky, Y. S., & Myakishev-Rempel, M. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.03.008 · Cited by 23
Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
Bettinetti‐Luque, M., Trujillo‐Estrada, L., García‐Fuentes, E., Andreo‐Lopez, J., Sanchez-Varo, R. M., Garrido‐Sánchez, L., Mediavilla, A. G., López, M. G., García‐Caballero, M., Gutiérrez, A., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16243 · Cited by 24
A glance through the effects of CD4 + T cells, CD8 + T cells, and cytokines on Alzheimer's disease
Afsar, A., Chen, M., Xuan, Z., & Li, Z. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.058 · Cited by 22
Khan, H., Naseem, T., Kaushik, P., Narang, J., Khan, R., Panwar, S., & Parvez, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102535 · Cited by 22
Hohsfield, L. A., & Humpel, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121930 · Cited by 23
Johansson, P., Almqvist, E. G., Wallin, A., Johansson, J.-O., Andreasson, U., Blennow, K., Zetterberg, H., & Svensson, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176760 · Cited by 20
Brain interleukins and Alzheimer’s disease
Abdelhamed, H. G., Hassan, A. A., Sakraan, A., Al-Deeb, R. T., Mousa, D. M., Ezz, H. S. A., Noor, N. A., Khadrawy, Y. A., & Radwan, N. M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01538-5 · Cited by 22
Improvement of Key Molecular Events Linked to Alzheimer’s Disease Pathology Using Postbiotics
Bulacios, G. A., Cataldo, P. G., Naja, J. R., Chaves, E., Taranto, M. P., Minahk, C. J., Hebert, E. M., & Saavedra, L. (2023) · ACS Omega · doi:10.1021/acsomega.3c06805 · Cited by 23
Rodríguez, J., Arévalo, J. D. S., Dennis, V. A., Rodríguez, A. M., & Giambartolomei, G. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1343503 · Cited by 21
Janus, C., & Golde, T. E. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.010 · Cited by 21
Self-citationLau, J. K. Y., Tian, M., Shen, Y., Lau, S., Fu, W., Fu, A. K. Y., & Ip, N. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-83932-4 · Cited by 22
Goodwin, M. S., Croft, C. L., Futch, H. S., Ryu, D. H., Ceballos‐Diaz, C., Liu, X., Paterno, G., Mejia, C., Deng, D. Z., Menezes, K., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00361-z · Cited by 20
Self-citationPark, S. M., Shin, J. H., Moon, G. J., Cho, S. I., Lee, Y. B., & Gwag, B. J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-106 · Cited by 22
Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
Ibanez, K. R., McFarland, K. N., Phillips, J., Allen, M., Lessard, C. B., Zobel, L., De La Cruz, E. G., Shah, S., Vo, Q., Wang, X., et al. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01044-1 · Cited by 18
Self-citationInterferons: A molecular switch between damage and repair in ageing and Alzheimer’s disease
Gorlé, N., & Vandenbroucke, R. E. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111148 · Cited by 22
Yang, G., Hu, Y., Qin, X., Sun, J., Miao, Z., Wang, L., Ke, Z., & Zheng, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17848 · Cited by 20
Ball, B. K., Kuhn, M. K., Fleeman, R. M., Proctor, E. A., & Brubaker, D. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-62155-3 · Cited by 17
Neuroimmune interactions in Alzheimer's disease—New frontier with old challenges?
Prokop, S., Lee, V. M. ‐., & Trojanowski, J. Q. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.10.002 · Cited by 19
NSAIDs may protect against age-related brain atrophy
Bendlin, B. B., Newman, L. M., Ries, M. L., Puglielli, L., Carlsson, C. M., Sager, M. A., Rowley, H. A., Gallagher, C. L., Willette, A. A., Alexander, A. L., et al. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00035 · Cited by 20
Recent Advances in Progresses and Prospects of IL-37 in Central Nervous System Diseases
Li, X., Yan, B., Du, J., Xu, S., Liu, L., Pan, C., Kang, X., & Zhu, S. (2022) · Brain Sciences · doi:10.3390/brainsci12060723 · Cited by 17
Iban‐Arias, R., Trageser, K. J., Yang, E., Griggs, E., Radu, A., Naughton, S. X., Rahim, M. A., Oguchi, T., Raval, U., Palmieri, J., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-221046 · Cited by 16
Chiarini, A., Armato, U., Hu, P., & Prà, I. D. (2020) · Cells · doi:10.3390/cells9061386 · Cited by 17
Muraleedharan, A., Rotem‐Dai, N., Strominger, I., Anto, N. P., Isakov, N., Monsonego, A., & Livneh, E. (2020) · Glia · doi:10.1002/glia.23921 · Cited by 21
Widespread Neuronal Transduction of the Rodent CNS via Neonatal Viral Injection
Kim, J., Grunke, S. D., & Jankowsky, J. L. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3271-9_17 · Cited by 15
Adeno-Associated Virus Delivery Limitations for Neurological Indications
Benatti, H. R., & Gray‐Edwards, H. L. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.29196.hrb · Cited by 15
Cha, J., Filatov, G., Smith, S. J., Gammaitoni, A. R., Lothe, A., & Reeder, T. (2023) · Epilepsia Open · doi:10.1002/epi4.12873 · Cited by 14
Existence of different types of senile plaques between brain and spinal cord of TgCRND8 mice
Yuan, Q., Su, H., Zhang, Y., Chau, W. H., Ng, C. T., Wu, W., & Lin, Z. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.006 · Cited by 13
Whole-food diet worsened cognitive dysfunction in an Alzheimer's disease mouse model
Parrott, M. D., Winocur, G., Bazinet, R. P., David, W. L., & Greenwood, C. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.013 · Cited by 14
Li, D., & Yu, F. (2017) · Journal of Gerontological Nursing · doi:10.3928/00989134-20170519-01 · Cited by 16
Neuroinflammation to neurodegeneration: Boulevard of broken nerves
Attiq, A., Afzal, S., Raman, H., & Ahmad, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115015 · Cited by 13
Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease
Liu, H., Zhou, Y., & Song, W. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108263 · Cited by 18
Effects of Microglial Cytokines on Alzheimer’s Disease-Related Phenomena
Ji, Y., Wang, X., Kalicki, C. H., Menta, B. W., Baumgardner, M., Koppel, S. J., Weidling, I. W., Ortiz, J. P., Wilkins, H., & Swerdlow, R. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180820 · Cited by 12
Tolstova, T. V., Dotsenko, E., Luzgina, N. G., & Rusanov, A. L. (2024) · Biomedicines · doi:10.3390/biomedicines12102243 · Cited by 13
Experimental peri-implantitis induces neuroinflammation: An exploratory study in rats
Cafferata, E. A., Ramanauskaitė, A., Cuypers, A., Obreja, K., Dohle, E., Ghanaati, S., & Schwarz, F. (2024) · BMC Oral Health · doi:10.1186/s12903-024-04995-z · Cited by 12
Neuroinflammation als Motor der Alzheimer-Erkrankung
Castro‐Gomez, S., Binder, J., & Heneka, M. T. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0778-3 · Cited by 17
Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β
Anastasio, T. J. (2014) · Molecular BioSystems · doi:10.1039/c4mb00457d · Cited by 13
Do Sleep Disturbances have a Dual Effect on Alzheimer’s Disease?
Arjmandi-Rad, S., Ebrahimnejad, M., Zarrindast, M., & Vaseghi, S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01228-1 · Cited by 13
Adeno-associated virus 2/9 delivery of Cre recombinase in mouse primary afferents
Abdallah, K., Nadeau, F., Bergeron, F., Blouin, S., Blais, V., Bradbury, K. M., Lavoie, C. L., Parent, J., & Gendron, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-25626-y · Cited by 11
Chung, H.-S., Kim, S.-N., Jeong, J.-H., & Bae, H. (2013) · Neurochemical Research · doi:10.1007/s11064-013-0983-6 · Cited by 10
Quan, Q., Ma, X., Feng, J., Li, W., & Li, X. (2025) · Neuropeptides · doi:10.1016/j.npep.2025.102514 · Cited by 9
Recent advances in Alzheimer’s disease pathogenesis and therapeutics from an immune perspective
Nguyen, T.-D., Dang, L. N., Jang, J., & Park, S. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00631-0 · Cited by 9
Liu, H., Li, J., Wang, X., Luo, S., Luo, D., Ge, W., & Ma, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03083-x · Cited by 9
Belaïd-Nouira, Y., Bakhta, H., Samoud, S., Trimech, M., Haouas, Z., & Cheikh, H. B. (2013) · Nutritional Neuroscience · doi:10.1179/1476830512y.0000000048 · Cited by 9
de Souza, M. Â. A., de Lorena, V. M. B., Correia, M. T. D. S., Pereira‐Neves, A., & de Figueiredo, R. C. B. Q. (2018) · Toxicon · doi:10.1016/j.toxicon.2018.11.309 · Cited by 9
Abe, K., Chiba, Y., Hattori, S., Tamazawa, A., Yoshimi, A., Katsuse, O., & Suda, A. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116829 · Cited by 9
Malm, T., Magga, J. M., & Koıstınaho, J. (2012) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-011-0004-z · Cited by 9
Verbeeck, C., Carrano, A., Chakrabarty, P., Jankowsky, J. L., & Das, P. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.010 · Cited by 8
Self-citationCytokine changes in cerebrospinal fluid following vascular surgery on the thoracic aorta
Pereira, C., Perera, A. H., Rudarakanchana, N., Harris, B. H. L., Giovannantonio, M. D., Taylor-Robinson, S. D., Dani, M., & Fertleman, M. B. (2022) · Scientific Reports · doi:10.1038/s41598-022-16882-0 · Cited by 7
Puoliväli, J. T., Nurmi, A., Miettinen, T.-K., Soleti, A., Riccardino, F., Kalesnykas, G., Heikkinen, T., Vartiainen, N. E., Pussinen, R., Tähtivaara, L., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110881 · Cited by 8
Tziveleka, L., Cascione, M., Pellegrino, P., Bianco, A., Leporatti, S., & Matteis, V. D. (2025) · Ibrain · doi:10.1002/ibra.12199 · Cited by 8
Dental X-ray exposure and Alzheimer’s disease: A hypothetical etiological association
Rodgers, C. C. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.03.016 · Cited by 10
Pereira, C., Dani, M., Taylor-Robinson, S. D., & Fertleman, M. B. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s364954 · Cited by 6
Ablinger, I., Dressel, K., Rott, T., Lauer, A. A., Tiemann, M., Batista, J. P., Taddey, T., Grimm, H. S., & Grimm, M. O. W. (2022) · Biomedicines · doi:10.3390/biomedicines10112922 · Cited by 8
Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy
Levites, Y., Funk, C. C., Wang, X., Chakrabarty, P., McFarland, K. N., Bramblett, B., O’Neal, V., Liu, X., Ladd, T. B., Robinson, M., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00453-4 · Cited by 6
Self-citationQin, S., Fang, J., He, X., Yu, G., Yi, F., & Zhu, G. (2024) · Biology · doi:10.3390/biology13070544 · Cited by 6
Rheopheresis as a causal therapy option for systemic scleroderma (SSc)
Lutze, S., Daeschlein, G., Konschake, W., & Jünger, M. (2017) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-179204 · Cited by 5
The Amyloid-beta rich CNS environment alters myeloid cell functionality independent of their origin
Drost, N., Houtman, J., Cseresnyés, Z., Niesner, R. A., Rinnenthal, J.-L., Miller, K. R., Prokop, S., & Heppner, F. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-63989-3 · Cited by 5
Microglia: Neuroprotective and Neurodestructive Properties
Harry, G. J., & McPherson, C. A. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_55 · Cited by 6
WATANABE, C., Seigneuret, M., Staneva, G., Puff, N., & Angelova, M. I. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.04.027 · Cited by 5
Effects of a Multimerized Recombinant Autoantibody Against Amyloid-β
Albus, A., Kronimus, Y., Neumann, S., Vidovic, N., Frenzel, A., Kühn, P., Seifert, M., Ziehm, T., van der Wurp, H., & Dodel, R. C. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.03.006 · Cited by 5
Juárez‐Cedillo, T., Martínez‐Rodríguez, N., Vargas‐Alarcón, G., Juárez‐Cedillo, E., Valle-Medina, A., Garrido-Acosta, O., & Ramírez, A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.952173 · Cited by 5
Kokhan, V. S., Levashova, A. I., Nesterov, M. S., Pikalov, V. A., & Chicheva, M. M. (2025) · Biology · doi:10.3390/biology14060682 · Cited by 4
Moore, B. D., Ran, Y., Goodwin, M. S., Komatineni, K., McFarland, K. N., Dillon, K. D., Charles, C. N. W., Ryu, D., Liu, X., Prokop, S., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101146 · Cited by 4
Self-citationAnisomycin alleviates cognitive impairments and pathological features in 3xTg-AD mice
Jiao, J., Hu, Y., Cui, Y., Tuo, C.-M., Wang, Y.-X., Li, X., Zhang, Y., & Wu, M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110159 · Cited by 4
TAPPing into the potential of inducible tau/APP transgenic mice
Xu, G. M., Ulm, B. S., Howard, J. C., Fromholt, S., Lü, Q., Lee, B. B., Walker, A. P., Borchelt, D., & Lewis, J. M. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12791 · Cited by 4
Monitoring the Cerebrospinal Fluid Cytokine Profile Using Membrane-Based Antibody Arrays
González-Morales, A., Lachén‐Montes, M., Fernández‐Irigoyen, J., & Santamaría, E. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9706-0_14 · Cited by 4
Inflammation in Alzheimer’s disease: do sex and APOE matter?Preprint
Duarte‐Guterman, P., Albert, A., Inkster, A. M., Barha, C. K., Galea, L. A. M., & Initiative, O. B. O. T. A. D. N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/741777 · Cited by 4
Dual role of innate immune activation in cerebral small vessel disease
Peng, Y., Sun, Y., Song, X., Jin, C. J., Yin, X., & Zheng, X. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115178 · Cited by 4
Tognoni, C. M., Biswas, R. G., Suar, Z. M., Carreras, I., Dedeoglu, A., & Jenkins, B. G. (2026) · Scientific Reports · doi:10.1038/s41598-025-32797-y · Cited by 3
Unraveling the enigma: housekeeping gene Ugt1a7c as a universal biomarker for microglia
Kim, W., Kim, M.-J., & Kim, B. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1364201 · Cited by 3
How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?
Donato, L., Mordà, D., Scimone, C., Alibrandi, S., D’Angelo, R., & Sidoti, A. (2023) · Biomedicines · doi:10.3390/biomedicines11072035 · Cited by 3
Ma, L., Zhao, Y. Q., Cai, C., Qs, L., Hu, X., & Wang, L. (2026) · Cells · doi:10.3390/cells15141291 · Cited by 2
The contribution of inflammation to Alzheimer's disease in Down syndrome
Martini, A. C., Kloske, C. M., Wilcock, D. M., & Head, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00016-5 · Cited by 3
Suzuki, R., Takigawa, T., Nagaishi, M., Hyodo, A., & Suzuki, K. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.03.002 · Cited by 1
Impact of physical activity on the development of Alzheimer's disease
Paśnik, J., Sendecka, G., Kistela, N., Hądzlik, I., Durowicz, M., & Piotrowski, J. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.71.51112 · Cited by 2
Monitoring Cerebrospinal Fluid Inflammatory Mediators by Olink Target 48 Cytokine Panel
Zambom-Ferraresi, F., Zambom-Ferraresi, F., Izco-Cubero, M., Martínez‐Velilla, N., Extramiana, L., Fernández‐Irigoyen, J., Santamaría, E., Llamas-Urbano, A., Hanaee, Y., Martinez-Moreno, J. M., et al. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4462-1_5 · Cited by 1
Role and relation of cell death in Alzheimer’s disease
Hoang, D. A., Le, D. A., Do, T. M. H., & Than, V. T. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2025.06.024 · Cited by 2
Moreira, I. P., Serrão, P., Sequeira, L., Sá, M. J., Vieira‐Coelho, M. A., & Guimarães, J. (2025) · Neurological Research · doi:10.1080/01616412.2025.2542944 · Cited by 1
Canal, C., Aguilar, K., Comes, G., Sanz, E., Giralt, M., Sanchís, P., & Hidalgo, J. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02101-9 · Cited by 2
Neuroinflammation in Alzheimer's Disease Continuum
Sag, A. T., & Yemişçi, M. (2020) · Neurological Sciences and Neurophysiology · doi:10.4103/nsn.nsn_190_20 · Cited by 1
The Role of Adaptive and Innate Immunity in Alzheimer’s Disease
Holmes, C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108539623.012 · Cited by 1
Influence of Selected Diets on Neural Insulin Activity and Cognitive Function
Parrott, M. D. (2014) · TSpace (University of Toronto) · Cited by 1
Immune regulations in a Drosophila model of Alzheimer's disease
Maksoud, É. (2012) · theses.fr (ABES) · doi:10.70675/1c0d2d8cz36d8z4785zbf04z131c36133de9 · Cited by 2
Sarlus, H. (2015) · Figshare
Bone Marrow-Derived Cell Accumulation in the Brain in a Murine Model of Alzheimer’s Disease
Barr, C. (2013) · Summit (Simon Fraser University)
Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
Dionísio, P. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Adipokines and Alzheimer's Disease
Sortino, M. A., Merlo, S., & Spampinato, S. F. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733434-00130
Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
Farmácia, F. D. (2014)
Hettinger, J. C. (2017) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7jq10fn
Intraspinal Delivery of Recombinant AAV-Mediated Interleukin-10 Modifies Disease in ALS Mice
Chakrabarty, P., & Ayers, J. I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00011-9
Self-citationMorin‐Alain, V. (2019) · Corpus Université Laval (Université Laval)
Rôle des récepteurs P2X4 dans la dégradation d’ApoE : implication dans la maladie d’Alzheimer
Hua, J. (2019) · theses.fr (ABES) · doi:10.70675/9a24edbdzd1fbz4cecza5eaz617931d6db22
Study of the importance of the choroid plexus in peripheral and brain inflammation
Gorlé, N. (2020) · Ghent University Academic Bibliography (Ghent University)
Metadata
- Authors
- Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., & Das, P.
- Affiliations
- Mayo Clinic in Florida (US)
- Corresponding author
- Das, Pritam
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-10-13
- Volume
- 24
- Issue
- 2
- Pages
- 548-559
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3083918
- OpenAlex
- W1977896329
- Cited by
- 328
- References
- 50
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 19 · 2023: 13 · 2022: 34 · 2021: 21 · 2020: 26 · 2019: 23 · 2018: 23 · 2017: 23 · 2016: 19 · 2015: 20 · 2014: 16 · 2013: 19 · 2012: 21
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- American Health Assistance Foundation (AHAF3J)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- interleukin-6, reactive gliosis, amyloid-beta deposition, Alzheimer's disease, neuroinflammation, APP processing, microglial phagocytosis, TgCRND8 mice, Tg2576 mice, amyloid plaque clearance
- MeSH terms
- Alzheimer Disease, Animals, Gliosis, Humans, Inflammation, Mice, Transgenic, Phagocytosis, Interleukin-6, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.